Hydroxychloroquine as Oral Antidiabetic Agent During Coronavirus Pandemic
<p>The coronavirus disease 2019 (COVID-19) is spreading rapidly. Hydroxychloroquine (HCQ), an old drug for treatment of malaria and autoimmune disease with acceptable safety, has shown promising but yet unproven effect against COVID-19 infection. HCQ is an approved agent by the Drug Controller...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
Global Journal of Infectious Diseases and Clinical Research - Peertechz Publications,
2020-05-07.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|